Funding Announcements

Massachusetts Life Sciences Center (MLSC) Open Programs

The Massachusetts Life Sciences Center (MLSC) supports innovation, research & development, commercialization, and manufacturing activities in the fields of biopharma, medical device, diagnostics, and digital health. Competitive Capital Programs:

Novel Therapeutics Delivery

Innovative new therapies are dependent on advancements in drug delivery. Increased drug complexity, the rise of biopharmaceuticals, novel technologies, and bioavailability challenges are all driving unprecedented technology innovation; however, the availability of such therapies is not accelerating at the rate with which technology is advancing. Existing therapies can also benefit from improved delivery methods and devices, increasing patient compliance and improving overall health through innovation at the intersection of engineering, biology, chemistry, and medicine.

Bits to Bytes

This program recognizes the importance of generating large, robust datasets and metadata to answer important scientific questions. Additionally, the program’s goal is to employ data analytics and/or machine learning techniques to develop a greater understanding of various medical conditions to develop optimal treatments to improve patient health. Bits to Bytes also aims to develop the skillsets of data scientists in Massachusetts to strengthen our local industry and retain the next generation of talent in this competitive field.

Application Process: Interested parties should email Marc Scatamacchia at and Jessica Tytell at in Industry Engagement for assistance and instructions regarding the application process.

Deadline: Thursday, January 23, 2020

NSF – Accelerating Research through International Network-to-Network Collaborations (AccelNet)

The Accelerating Research through International Network-to-Network Collaborations (AccelNet) program goal is to accelerate scientific discoveries by connecting U.S. research networks with complementary networks abroad to address grand research challenges that will benefit from coordinated international cooperation aligned with an NSF Big Idea across any field of science or engineering supported by NSF.

The AccelNet solicitation offers two proposal categories:

  • Catalytic proposals will support developing or otherwise immature networks of networks. Catalytic networks should have a specific limited term goal that has the potential to catalyze a breakthrough for the network, for example, a new research approach, networking strategy, or collaborative technology.
  • Full-Scale Implementation proposals are envisioned as consisting of a core of networks in the U.S. and abroad that are operational, have established an understanding of the status of the research and researchers across their fields, and are well-positioned to engage each other to advance research.

Funding: NSF anticipates between $3 and $6 million per year to fund between seven and nine awards. Catalytic proposals will be funded for three years with a total budget of $750,000 and Full-Scale Implementation proposals will be funded up to five years with a total budget of $2 million..

Eligibility: While there are no limits on institutions, an individual PI or co-PI can only appear on one proposal per fiscal year.

Deadline:  For the next competition, Letters of Intent are due October 30, 2019, with full proposals due January 31, 2020.

NIH Launches Pilot Program

The new Online Partnership to Accelerate Research (OnPAR) is a collaboration between NIH and the contractor Leidos that will allow researchers upload unfunded NIH proposals to an online portal where potential funders can review the scores received from reviewers, and decide whether to provide money for the study.

The goal of OnPAR is to match quality biomedical research projects with priority areas of interest of private foundations, and pharmaceutical and biotech companies and/or other private biomedical research funders. OnPAR will eventually provide access to a global pipeline of research projects that can either supplement internal projects or provide innovative new ideas for future medical products.

If an applicant scored in the top 30% and is not funded by NIH, he/she is welcome to submit an abstract for consideration. Qualified applicants are invited to register with OnPAR and participate in the submission and review process. It is not necessary to re-write an application. OnPAR will accept the NIH abstract that was submitted by the applicant, and if invited, his/her submitted NIH application and Summary Statement.

For more information on the registration process click here.